NCT05587296 2026-02-03
OASIS-4
Bayer
Phase 3 Active not recruiting
Clinical Trials
10 trialsNCT05071729 2025-07-14
A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally
Bayer
Phase 1 Completed
NCT06219902 2024-05-08
A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women
Bayer
Phase 1 Completed
NCT05481528 2023-05-09
A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants
Bayer
Phase 1 Completed
NCT05351892 2022-07-19
A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants
Bayer
Phase 1 Completed
NCT04892914 2022-04-05
Embr Thermal Device for Hot Flash Management in Prostate Cancer
Embr Labs, Inc.
Phase NA Completed
NCT05061563 2022-03-17
A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults
Bayer
Phase 1 Completed
NCT04080297 2020-02-28
Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen
Que Oncology
Phase 1 Completed
NCT00196339 2016-07-22
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00886496 2012-06-20
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Enzon Pharmaceuticals, Inc.
Phase 1 Withdrawn